Traish Aisha S, Chodosh James
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Semin Ophthalmol. 2010 Sep-Nov;25(5-6):239-43. doi: 10.3109/08820538.2010.518895.
To evaluate how the advances in design of the Boston type I keratoprosthesis and in the treatment strategies to conquer the post operative complications have expanded the indications and application of this technology.
A review and analysis of the keratoprosthesis literature specifically examining design modifications, treatment of post operative complications, and patient selection was performed.
Over the past two decades, many modifications to the design of the Boston type I keratoprosthesis and treatment of the patient in the post operative period have occurred. Also, the technology has been more widely accepted as a primary surgical option for patients with a poor preoperative prognosis for traditional penetrating keratoplasty. The outcomes of visual acuity, retention, and post-operative infection rates have all significantly improved since the technology has been modified and offers patients an alternative for visual rehabilitation.
Thanks to advances in design and perioperative care, the boston type i keratoprosthesis can now be considered a viable option for surgical visual rehabilitation in many patients with corneal pathology, and in certain groups the primary surgical procedure of choice.
评估波士顿I型人工角膜的设计进展以及克服术后并发症的治疗策略如何扩大了该技术的适应症和应用范围。
对人工角膜文献进行综述和分析，特别关注设计改进、术后并发症的治疗以及患者选择。
在过去二十年中，波士顿I型人工角膜的设计和术后患者治疗发生了许多改进。此外，该技术已被更广泛地接受为传统穿透性角膜移植术前预后较差患者的主要手术选择。自从该技术改进以来，视力、植入物保留率和术后感染率的结果均有显著改善，并为患者提供了视觉康复的替代方案。
由于设计和围手术期护理的进展，波士顿I型人工角膜现在可被视为许多角膜病变患者手术视觉康复的可行选择，并且在某些群体中是首选的主要手术方法。
